Trio of biomarkers ‘may’ help identify kidney cancer

on March 16 | in Cancer Research & Technology, Kidney Cancer, Latest News, News, World News | by | with No Comments

Kidney Cross Close upA NEW immunoassay that tests for the presence of three biomarkers appears to be a valid screening method for the early detection of malignant kidney cancer, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

“Renal cell carcinoma, a malignant tumor arising from the kidney, is one of the most difficult forms of cancer to detect and treat properly because it remains silent until disseminating to other organs,” said Nam Hoon Cho, M.D., of the Department of Pathology at Yonsei University Health System in Seoul, Korea.

“Furthermore, because imaging, which is high-cost, is seldom performed without any specific reasons, developing a blood-tumor biomarker is a great chance to detect the silent killer.”

The new immunoassay developed by Cho and colleagues from Genomine Inc. measured the levels of three potential biomarkers for kidney cancer: nicotinamide N-methyltransferase (NNMT), L-plastin (LCP1) and nonmetastatic cells 1 protein (NM23A)….Read more

Source: www.medicalsearch.com.au

Pin It

Related Posts

Comments are closed.

« »

Scroll to top